Capabilities

Biotech license to AstraZeneca

AtheroGenics
2005

In connection with the firm's representation of AtheroGenics in a license agreement with AstraZeneca, our tax attorneys provided critical advice on a variety of international tax issues, including the mitigation and management of withholding tax requirements and the exploitation of incentives in overseas jurisdictions for pharmaceutical-related manufacturing activities.

Email Disclaimer